424
Participants
Start Date
November 30, 2003
Primary Completion Date
April 30, 2007
Study Completion Date
April 30, 2007
Botulinum Toxin Type A
100 U, repeated treatments at \> 4 month intervals up to Month 32, over a 36-month study period
Portland
Pinneberg
Gothenburg
Nottingham
Lead Sponsor
Allergan
INDUSTRY